Master in Biopharmaceuticals

Universidade Nova de Lisboa offers a Master's degree in Biopharmaceuticals. This programme focuses on Animal Cell Technology. It is a key area for discovering and developing complex biopharmaceuticals. Students study recombinant proteins, vaccines, and viral vectors. These are used in gene therapy.

The programme is located at the Campus de Campolide in Lisbon. The university can be contacted by phone at +351 213 715 600 or by email at reitoria@unl.pt. Information regarding tuition fees, specific start dates, and admission requirements is not detailed on this page. Prospective students should consult the university's official admissions portal for these details.

The Universidade Nova de Lisboa is committed to equality and inclusion. The university provides various resources for current students, faculty, and staff. It also offers information on general contacts, terms and conditions, and a privacy policy. The programme was last updated on September 8, 2022.

Universidade Nova de Lisboa, also known as NOVA, is located in Portugal. It is a public university. NOVA offers a Pre-University Programme called SUPERNOVA. This programme is designed for international students. It helps them prepare for higher education in Europe. The programme provides academic skills for bachelor's degrees. It also offers access to NOVA or its partner universities.

The university is known for its global and civic mission. It aims to serve society through excellent teaching and research. NOVA is committed to a strong sense of community. It respects human rights and values honesty and integrity. The university also emphasizes public service and inclusion. NOVA is part of the EUTOPIA alliance. This alliance connects ten European universities with shared values.